Monday, September 30, 2013

Global Industry Medical Cameras Market Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: Research Report



Medical Cameras Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Medical cameras are used to examine the interior of a hollow organ or cavity of the body for medical purpose and provide investigation of medical symptoms, diagnosis confirmation and also treatment such as widening of a constricted esophagus, extracting off a polyp or removal of a foreign object or cauterization of a bleeding vessel. Surgical procedures using medical cameras are less invasive than traditional surgical procedures.


The global medical cameras market is categorized as follows:

Product types

  • Endoscopy cameras
  • Dermatology cameras
  • Ophthalmology cameras
  • Dental cameras

Technology

  • Digital imaging (3D/2D)
  • Liquid lens technology
  • Optical coherence tomography scanner

At present, North America dominates the global medical cameras market and is followed by Europe due to the early entrance of new competitors and corresponding release of new high definition cameras in these regions. Emerging economies of Asia-Pacific, Latin America and Middle East are expected to undergo rapid growth in medical cameras market due to rising demand for minimally invasive surgical procedures and increased adoption of high definition technology.

Some of the major factors driving the global medical cameras market include growing health awareness among the patient base, aging population and related increase in healthcare utilization, better health outcomes and improved efficiency procedures and advancement in HD camera technology.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175726

Some of the prominent players contributing to the global medical cameras market include Carestream Health, Inc., Gendex Corporation, Canon, Inc., Canfield Scientific, Inc., Stryker Corporation, Allied Vision Technologies GmbH, Olympus Corporation, Sensor Technologies America., Inc., and Videology Imaging Solutions, Inc.,

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/175726

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments


Latest Reports:

Central Nervous System (CNS) Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/central-nervous-system-cns-biomarkers-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Biomarkers are used to indicate the biological state of a process, pathogenic process or therapeutic action.  Biomarkers facilitate understanding the development of a chronic disease, relationship between exposure to environmental chemicals and identification of subgroups of people who are relatively at high risk of developing disease. Continued development in related technologies such as genomics, proteomics and imaging system has accelerated the development of biomarkers. With the complexity of Central Nervous System (CNS), it is considered that biomarkers will play a vital role in identifying several neurodegenerative diseases at early stage, provide more accurate diagnosis and better treatment.

The global market for Central Nervous System biomarkers has been growing rapidly over the past two decades and is expected to continue further under the influence of increased governmental support, rapidly increasing aging population and advancements in supporting technologies such as genomics, proteomics and imaging technologies. The world is witnessing a rapid growth in aging population leading to high prevalence of many CNS disorders such as Parkinson’s, multiple sclerosis and Alzheimer’s disease. The Aging Research Center, Karoliska Institute, Sweden suggests that approximately 24 million are affected with Alzheimer’s disease worldwide. 

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175728

These diseases incur significant burden on society, to overcome these burdens governments are supporting private and public laboratories by funding to continue their development process. United States government has proposed to spend USD 140.8 billion in the fiscal 2013 to support research and development program across the country. Geographically, North America represents the largest market as healthcare infrastructure ismore advanced as compared to other regions around the globe and it also has a large population base suffering from CNS diseases. The emerging markets including India, china, Brazil and Mexico are poised to show substantial growth due to continuously improving healthcare facilities in these nations.


Hemoglobin A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/hemoglobin-a1c-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Blood glucose testing at regular intervals is very crucial for diabetic patients, in order to keep a track of fluctuating glucose levels in the blood. The crucial aim of diabetes treatment is to ensure normal levels of blood glucose. Hemoglobin A1c (Hb A1c) is a lab test that gives an idea about average levels of blood sugar for a period of around three months. The test results give an idea about the efficacy of diabetes treatment plans. It provides insights on the following parameters:

  • Success of the designed diabetes treatment plan.
  • Accuracy of test results

The mechanism of test includes linking of hemoglobin to glucose molecules in red blood cells. With increasing levels of glucose in red blood cells, there is a high possibility of hemoglobin molecules being glycated or linked with glucose molecules. It is recommended to perform the test atleast twice in a year. A1c levels are reported in terms of percentages. Presently, American Association of Clinical Endocrinologists recommends around 6.5% A1c to be normal concentration and American Diabetes Association recommends less than 7.0% A1c in the blood cells.

Click Here To Download Detail Report:  http://www.marketresearchreports.biz/sample/toc/175727

The market for hemoglobin A1c testing is witnessing a consistent growth trend majorly due to increasing incidence of diabetes mellitus across the globe. According to the data enumerated by WHO, there are around 347 million diabetic patients worldwide and diabetes will be seventh leading cause of death by 2030. Currently, with the approval of U.S. FDA for these tests or assays for diagnosing diabetes by healthcare professionals, the demand and acceptance of HbA1c tests will further increase.

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Global AFP Testing Market Research Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: Top Rated Report

AFP Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Alpha-fetoprotein (AFP) is the most widely found plasma protein in human fetus.  The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4.  It is a major plasma protein which is produced during fetal development in yolk sac and the liver.  AFP is a glycoprotein which is found in monomeric, dimeric and trimeric forms. The protein is normally made by immature liver cells in the fetus therefore; infants have higher levels of AFP, which falls to normal adult level by the end of first year. 


Usually, low level of AFP protein is found in pregnant women’s and in the blood of healthy adults. However, biochemical tests are performed to check the level of AFP protein in pregnant women’s blood. The high or low level of AFP helps doctor to estimate the chances of birth defect or other problems. These AFP based screening test helps to determine certain chromosomal aberrations such as Down’s syndrome or Edwards’s syndrome, neural tube defects and certain types of cancer.

AFP screening tests are being used widely and many of them are commercially available due to their sensitivity in cancer diagnosis. Usually, level of AFP in human blood is below 10ng/ml but it elevates up to 500ng/ml in patients suffering from chronic hepatitis. In addition, high level of AFP is also witnessed in patients suffering lymphoma, Hodgkin’s disease, brain tumors and renal cancer. Cancer diagnostic segment is growing exponentially as the researchers are discovering new techniques and specific antigens to further enhance the treatment mode. Therefore, AFP testing market is expected to grow with rise in cancer incidences. Similarly, growth in AFP testing market is also poised to grow with rise in geriatric population, which is more susceptible to diseases and tumor development. 

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175729

Some of the market players in this industry are Abbott Laboratories, Biomedical Diagnostics, Bio-Rad Laboratories, Beckman Coulter, Kreatech Diagnostics, Roche Diagnostics and other significant players.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

To buy the copy of this report, visit: http://www.marketresearchreports.biz/analysis/175729

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments


Latest Reports:

Central Nervous System (CNS) Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/central-nervous-system-cns-biomarkers-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Biomarkers are used to indicate the biological state of a process, pathogenic process or therapeutic action.  Biomarkers facilitate understanding the development of a chronic disease, relationship between exposure to environmental chemicals and identification of subgroups of people who are relatively at high risk of developing disease. Continued development in related technologies such as genomics, proteomics and imaging system has accelerated the development of biomarkers. With the complexity of Central Nervous System (CNS), it is considered that biomarkers will play a vital role in identifying several neurodegenerative diseases at early stage, provide more accurate diagnosis and better treatment.

The global market for Central Nervous System biomarkers has been growing rapidly over the past two decades and is expected to continue further under the influence of increased governmental support, rapidly increasing aging population and advancements in supporting technologies such as genomics, proteomics and imaging technologies. The world is witnessing a rapid growth in aging population leading to high prevalence of many CNS disorders such as Parkinson’s, multiple sclerosis and Alzheimer’s disease. The Aging Research Center, Karoliska Institute, Sweden suggests that approximately 24 million are affected with Alzheimer’s disease worldwide. 

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/175728

These diseases incur significant burden on society, to overcome these burdens governments are supporting private and public laboratories by funding to continue their development process. United States government has proposed to spend USD 140.8 billion in the fiscal 2013 to support research and development program across the country. Geographically, North America represents the largest market as healthcare infrastructure ismore advanced as compared to other regions around the globe and it also has a large population base suffering from CNS diseases. The emerging markets including India, china, Brazil and Mexico are poised to show substantial growth due to continuously improving healthcare facilities in these nations.


Hemoglobin A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/hemoglobin-a1c-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Blood glucose testing at regular intervals is very crucial for diabetic patients, in order to keep a track of fluctuating glucose levels in the blood. The crucial aim of diabetes treatment is to ensure normal levels of blood glucose. Hemoglobin A1c (Hb A1c) is a lab test that gives an idea about average levels of blood sugar for a period of around three months. The test results give an idea about the efficacy of diabetes treatment plans. It provides insights on the following parameters:

  • Success of the designed diabetes treatment plan.
  • Accuracy of test results

The mechanism of test includes linking of hemoglobin to glucose molecules in red blood cells. With increasing levels of glucose in red blood cells, there is a high possibility of hemoglobin molecules being glycated or linked with glucose molecules. It is recommended to perform the test atleast twice in a year. A1c levels are reported in terms of percentages. Presently, American Association of Clinical Endocrinologists recommends around 6.5% A1c to be normal concentration and American Diabetes Association recommends less than 7.0% A1c in the blood cells.

Click Here To Download Detail Report:  http://www.marketresearchreports.biz/sample/toc/175727

The market for hemoglobin A1c testing is witnessing a consistent growth trend majorly due to increasing incidence of diabetes mellitus across the globe. According to the data enumerated by WHO, there are around 347 million diabetic patients worldwide and diabetes will be seventh leading cause of death by 2030. Currently, with the approval of U.S. FDA for these tests or assays for diagnosing diabetes by healthcare professionals, the demand and acceptance of HbA1c tests will further increase.

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948